Create accountLogin

Recent searches

No recent searches

Search options

Only available when logged in.
med-mastodon.com is one of the many independent Mastodon servers you can use to participate in the fediverse.
Medical community on Mastodon

Administered by:

Server stats:

423
active users

med-mastodon.com: AboutProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.3.7

#dosing

0 posts0 participants0 posts today
Public
Tim Street

GLP1-RAs in Type 1 Diabetes: Dosing and Pharmacokinetics
As we discussed in the previous article, people are starting to use incretins as an adjunct therapy in the treatment of type 1 diabetes. All off label, of course.

Anyone familiar with these drugs will know that they are indicated to be injected once a wee
diabettech.com/glp1-ra/glp1-ra
#GLP1RA #Dosing #Halflife #Mounjaro #Semaglutide #Tirzepatide #variability #WeGovy

Diabettech - Diabetes and Technology | Where Diabetes and Technology meet · GLP1-RAs in Type 1 Diabetes: Dosing and Pharmacokinetics | Diabettech - Diabetes and TechnologyAs we discussed in the previous article, people are starting to use incretins as an adjunct therapy in the treatment of type 1 diabetes. All off label, of course. Anyone familiar with these drugs will know that they are indicated to be injected once a week. A model that's easy to follow, doesn't involve too
Public
Giuseppe Michieli

Influence of #mRNA #Covid19 #vaccine #dosing interval on #risk of #myocarditis, Nat Commun.: nature.com/articles/s41467-024

Here we show that longer intervals between each consecutive dose, including #booster, may decrease occurrence of vaccine-associated myocarditis by up to a factor of 4, especially under age 50. These results suggest that a minimum 6-month interval might be required when scheduling additional booster vaccination.

NatureInfluence of mRNA Covid-19 vaccine dosing interval on the risk of myocarditis - Nature CommunicationsDosing interval has been suggested as a modifier in the risk of myocarditis associated with Covid-19 mRNA vaccination. Here, the authors show that longer intervals between each consecutive dose, including booster, may decrease the occurrence of myocarditis, especially under age 50.
ExploreLive feeds
About